Acute Myeloid Leukaemia: New Targets and Therapies
Institute of Clinical Science, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Laboratory of Protein Biochemistry, Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, 50-383 Wroclaw, Poland
Author to whom correspondence should be addressed.
Received: 30 October 2017 / Revised: 22 November 2017 / Accepted: 29 November 2017 / Published: 30 November 2017
Note: In lieu of an abstract, this is an excerpt from the first page.
The most common acute hematological malignancy in adults is acute myeloid leukaemia (AML), accounting for more than 80% of cases in patients over 60 years of age [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Brown, G.; Marcinkowska, E. Acute Myeloid Leukaemia: New Targets and Therapies. Int. J. Mol. Sci. 2017, 18, 2577.
Brown G, Marcinkowska E. Acute Myeloid Leukaemia: New Targets and Therapies. International Journal of Molecular Sciences. 2017; 18(12):2577.
Brown, Geoffrey; Marcinkowska, Ewa. 2017. "Acute Myeloid Leukaemia: New Targets and Therapies." Int. J. Mol. Sci. 18, no. 12: 2577.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.